CD20-directed CAR-T cells

CD20 CAR-T cells · Shanghai Longyao Biotechnology Inc., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD20-directed CAR-T cells, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma [Phase 1, Phase 2]

See pricing